| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $6.1M | -74.5% | -30.0% |
| SG&A Expense | $2.8M | -12.2% | -24.6% |
| Operating Income | -$8.9M | +67.2% | +28.4% |
| Income Tax | $0 | — | — |
| Net Income | -$8.6M | +67.8% | +25.3% |
| EPS (Basic) | -$3.22 | +71.5% | -685.4% |
| EPS (Diluted) | -$3.22 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.3M | +49.7% | -73.6% |
| Current Assets | $32.6M | -18.4% | -58.5% |
| Total Assets | $39.6M | -16.9% | -56.2% |
| Current Liabilities | $11.0M | +2.0% | +26.8% |
| Total Liabilities | $16.0M | -0.5% | +8.2% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.0M | — | — |
| Capital Expenditures | $508K | — | — |
| Investing Cash Flow | $19.6M | — | — |
| Financing Cash Flow | $2.0M | — | — |
| Free Cash Flow | -$42.5M | — | — |
| -685.4% |
| $23.6M |
| -20.2% |
| -68.7% |